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Head and neck cancer represent nearly 12% of total malignancies, including the face, the 
oropharynx, the parotid gland and other salivary glands, the orbit, the jaw , the sinuses and 
other parts of the face including the skin. These anatomical sites might be affected by other 
varieties of cancer, such as basal cell carcinoma, squamous-cell carcinoma, fibro sarcoma, 
osteogenic sarcoma and jaw lymphoma, and non-Hodgkin’s lymphoma and Hodgkin’s 
lymphoma.  Jaw lymphoma is nominated from other parts of the world and Africa, such as 
Burkitt lymphoma. Jaw lymphoma is quite different from Burkitt lymphoma in its clinical 
features, aetiology and even with regard to its treatment.  Jaw lymphoma is presented as 
having a very rapid onset with a fast spread to internal organs and the brain, while Burkitt 
lymphoma is a slowly growing tumour; it is well known that Burkitt lymphoma can be 
treated successfully by a few courses of cyclophosphamide (40 mg/square meter) but jaw 
lymphoma requires a more complicated regimen with combination of many 
chemotherapeutic agents, such as CHOP( therapeutic regimen of jaw lymphoma consist of 
eight doses over 24 weeks including 1.5mg/m2 Vincristine,50mg/m2 Adriamycin, 
1000mg/m2 Cyclophosphomide, 10mg/m2 Methotroxate and 50mg/m2 prednisolone )  and 
it rarely deposits its tumour to the lymph nodes. Cancer of the head and neck constitute an 
important section of the total cancers affecting the body, and oral cancer represents about 
4% of this; it is not necessary that all such cancers have nodal deposits in the neck, such jaw 
lymphoma or Burkitt Lymphoma. Malignant tumours such as squamous cell carcinoma – 
which form about 95% of oral cancers – and Melanoma – a highly malignant tumour with 
early metastasis – are rare and aggressive types of tumours and the survival rate is very low. 
Other malignant tumours, such as adenocarcinoma – which is a slowly growing malignant 
tumour – have less of a tendency for cervical node metastasis. 
Cancer of the paranasal sinuses is considered to be an aggressive type of malignancy with a 
tendency to invade the orbit and the base of the skull. The most common tumour of the 
sinuses is squamous cell carcinoma rather than adenocarcinoma, as a result of cellular 
changes from respiratory columnar type to squamous type due to the recurrence of infection 
and other irritating agents. These types of tumour metastasise in the cervical lymph nodes. 
Cancer of the oral cavity represents somewhat less than 4% of total cancer incidence but this 
might increase to more than 40% – as in India due to dietary causes such as spicy foods and 
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smoking – and these tumours appear as a fissure or exophytic growth or ulcer with white 
leukoplakia, and the most common site which is affected is the tongue and floor of the 
mouth. Both of these lesions in early metastasis affect the deep chain of the cervical lymph 
nodes, and the managements of these cases was based on a combination of three modalities 
in the form of radical surgery, chemotherapy and deep x-ray therapy. There is no possibility 
of a single technique for treatment in these cases. A frozen section in theatre is required for 
any assessment of the complete eradication of tumours 
Nowadays, chemotherapy has played an important role in the management of head and 
neck cancers due to advances in the manufacturing of these drugs and DXT (deep x-ray 
therapy) which have become more specific and more precise in targeting cancer tumours. 
One technique of note is the use of the gamma Knife (Cobalt 60) in the management of brain 
tumours and intraocular malignancies without evisceration of the eye ball (which can be 
very depressing and inconvenient for patients). 
The advancement of surgical management of head and neck tumours was based on 
advances in flap surgeries, such as a pedicle flaps like the forehead flap, the lateral cervical 
flap, the deltopectoral flap and the trapezius flap, or else by using free flaps like the forearm 
flap and the tapes dorsalis flap; these flaps are required for microanastomosis for the 
reconstruction the surgical defects after radical cancer surgery. We have not forgotten that 
the traditional use of radical neck dissection as a method of treatment for cervical lymph 
node metastasis has not often been used as a surgical procedure for the total radical excision 
of cervical lymph nodes with the radical excision of the sternomastoid muscle, the accessory 
nerve, deep cervical fascia and internal jugular vein ligation. This procedure has become less 
popular due to the creation of an obvious vertical band of scars extending all over the neck 
and dropping off the shoulder with a superficial exposure of the carotid tree just below the 
skin. This problem was overcome by the advancement of the trapezius flap so as to cover 
the carotid tree and so avoid any traumatic injuries to carotid content. These complications 
have been avoided by advances in other techniques, such as selective neck dissection, 
functional neck dissection and supraomohyoid neck dissection. 
The advancements of  different diagnostic tools for detection of any cervical lymph node 
metastasis and assessment of these deposit been used by application of ultra sonography , 
MRI  and CT scan with protocol for management of cervical lymph nodes metastasis is the 
basis for management of cervical lymph node metastasis. 
The most common malignant tumours of the orofacial region is basal cell carcinoma 
affecting the skin of the face and this is more common among white people who have less 
melanin pigment in their skin and who have continuous exposure to sun light. This tumour 
is a slowly growing type with a tendency to invade the underlying structures and it does not 
metastasis to the cervical lymph nodes. Squamous cell carcinoma represents about 95% of 
the total oral malignancies mainly affecting the tongue and the floor of the mouth with 
tendency for cervical lymph node deposits. The management of these tumours requires the 
application of all modalities of treatment, surgery, DXT and chemotherapy. 
Adenocarcinoma is less common in the oral cavity and affects the minor salivary glands – it 
is more common in the maxilla and it is a slowly growing tumour that rarely metastasises in 
the cervical lymph nodes and is less aggressive than adenocarcinoma of the gastro-intestinal 
tract, which is a highly malignant tumour with early metastasis in mesenteric lymph nodes. 
The eradication of these tumours is rather difficult due to their early metastasis and the 
complicated anatomy of the area, which makes radical surgery rather difficult. Recent 
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advances in chemotherapy have seen the application of Gemzar (gencitabin) (this drug 
interferes with the growth and spread of cancer cells by inducing apoptosis and ant 
metabolite and also been used with Carboplatin) – which is a specific chemotherapy for this 
type of malignancy and was a promising type of chemotherapy even in cases of fourth-stage 
of pancreatic adenocarcinoma. In the parotid glands, adenocarcinoma is common and also is 
mucoepidermoid carcinoma and other malignancies; only rarely is the parotid affected by 
malignant oncocytoma, this type of tumour metastasises in cervical lymph nodes and 
requires  radical resection of the tumour with chemotherapy and DXT. 
The majority of head and neck tumours require neck dissection at once, affecting the oral 
cavity and parotid region. However, tumours affecting the middle third of the face – such as 
the maxilla or the orbit – require radical surgery with flap reconstruction followed by DXT 
and chemotherapy, rather than radical neck dissection and as there is rarely any metastasis 
in the cervical lymph nodes. 
Melanoma of the orofacial tumour is a highly malignant type of tumour with a high 
tendency for early cervical metastasis, and the prognosis is not very promising. It requires 
multiple therapies for controlling its tumours, including chemotherapy and radical surgery, 
while melanoma of the lower limbs is less aggressive and responds to radical surgery and is 
diagnosed with lymphoscintigraphy. 
Current cancer research focused now a days on understanding on the response and 
resistance to treatment and apoptosis. Cancer treatment depend not only on cellular 
damages as achieved by chemotherapy and DXT but also on the ability of the cell to respond 
to damages by inducing apoptotic changes and mutation in apoptotic pathway to end with 
resistance to chemotherapy drugs and radiation. Mitochondria and cell surface receptors  
 
 
Fig. 1. Jaw lymphoma of the right side of the face of a 2 year old boy with a history of one 
month. 
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mediate the pathway of apoptosis and this pathways mediated by Bcl-2 family protein and 
the final excursion of cell death is performed by caspace cascade which is triggered by 
release cytochrome C from mitochondria. Most of the activity in the development of 
apoptosis drugs was concentrated on apoptosis inducers for treatment of malignancies. 
The future might be very promising for the control of lymph node deposits by using 
different methods of accessing neck dissection as well as the recent application of robot 
surgery (the da Vinci surgical robot system) which is more widely used in prostatic 
eradication than in any other specialty and which might be used in general surgery. 
However, this technique is limited in its application in all fields and even in head and neck 
malignancies. Expanding the role of DXT and chemotherapy as the first line of treatment 
and as a curative therapy without the need for radical neck dissection, either as an adjuvant 
with surgery or without as in jaw lymphoma (which is the only line of treatment for such a 
highly malignant tumour, being a fast spreading and fatal tumour). 
 
 
Fig. 2. Post-therapy after 2 years of treatment of jaw lymphoma by 6 courses of 
chemotherapy, with the collaboration with Prof. Selma Al Hadad, Paediatric Oncologist, 
Medical City Baghdad. 
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